Monthly Archives: November 2020

The Chief Corp Development Officer of SJW (NYSE: SJW) is Selling Shares

Yesterday, the Chief Corp Development Officer of SJW (SJW – Research Report), Andrew Walters, sold shares of SJW for $328.9K. See today’s analyst top recommended stocks >> Based on SJW’s latest earnings report for the quarter ending September 30, the

The CFO of Onconova Therapeutics (NASDAQ: ONTX) is Buying Shares

Yesterday, the CFO of Onconova Therapeutics (ONTX – Research Report), Mark Patrick Guerin, bought shares of ONTX for $5,555. This recent transaction increases Mark Patrick Guerin’s holding in the company by 20.5% to a total of $33.86K. In addition to

A Director at Rogers (NYSE: ROG) is Selling Shares

Today, a Director at Rogers (ROG – Research Report), Peter C. Wallace, sold shares of ROG for $708K. Following Peter C. Wallace’s last ROG Sell transaction on November 10, 2020, the stock climbed by 13.1%. In addition to Peter C.

A Director at CMC Materials is Exercising Options

Today it was reported that a Director at CMC Materials (CCMP – Research Report), Barbara Klein, exercised options to sell 6,625 CCMP shares at $33.89 a share, for a total transaction value of $1.01M. Following Barbara Klein’s last CCMP Sell

Noble Financial Keeps a Buy Rating on Gevo (GEVO)

Noble Financial analyst Poe Fratt maintained a Buy rating on Gevo (GEVO – Research Report) today and set a price target of $2.50. The company’s shares closed last Friday at $2.13. According to TipRanks.com, Fratt is a 1-star analyst with

Northland Securities Maintains Their Buy Rating on Kala Pharmaceuticals (KALA)

In a report released today, Tim Chiang from Northland Securities maintained a Buy rating on Kala Pharmaceuticals (KALA – Research Report), with a price target of $17.00. The company’s shares closed last Friday at $7.30. According to TipRanks.com, Chiang is